GlassScriptPhysician profile
Abbey M Carroll
NPI 1346459195
$2,242.20
in general payments reported to CMS, 2019-2025
21 companies · $661 in 2025
The $661 reported for 2025 was more than what 96% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $136 · 2021: $64.85 · 2022: $315 · 2023: $364 · 2024: $347 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,372.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $478.59 | 2022-2025 | Azstarys |
| Tris Pharma INC | $257.28 | 2019-2023 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $229.37 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $205.95 | 2019-2025 | |
| Hologic Sales and Service, LLC | $143.99 | 2023-2025 | Acessa Provu System, Fluent Fluid Management System |
| Ars Pharmaceuticals Operations, INC. | $124.96 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $117.82 | 2019-2023 | Rotateq, Vaqta, Gardasil 9 |
| Supernus Pharmaceuticals, INC. | $116.99 | 2024-2025 | Qelbree |
| Collegium Pharmaceutical, INC. | $112.09 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $90.00 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $73.80 | 2021-2025 | Uzedy |
| Sanofi-Aventis U.S. LLC | $62.71 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $60.78 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $42.54 | 2023-2024 | Flumist Quadrivalent |
| Biomerieux INC | $24.74 | 2024 | Biofire Spotfire Respiratory (R) Panel |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $22.51 | 2020 | |
| Seqirus USA INC | $22.39 | 2025 | Fluad, Flucelvax |
| Global Blood Therapeutics, INC. | $17.90 | 2022 | |
| Glaxosmithkline, LLC. | $13.34 | 2019 | |
| Shire North American Group INC | $12.90 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abbey Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.